Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05832463 · ClinicalTrials.gov registry record · NA

Effects of a Novel Supplement on Glycemic Variability Measured by Continuous Glucose Monitoring

A NA study of Healthy, sponsored by dōTERRA International.

Completed
Registry status
NA
Development phase
43
Enrollment target
1
Study location

NCT05832463: Completed NA study of Healthy, sponsored by dōTERRA International.

NCT05832463 is a NA study of Healthy that has completed, run by dōTERRA International. The registered enrollment target is 43 participants, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (93% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05832463, a NA study of Healthy, has completed, sponsored by dōTERRA International.

COMPLETED
Registry status
NA
Development phase
43 participants
Enrollment target
1
Study location

Study Summary

This is a two-cohort, crossover pilot study to determine interstitial glucose levels coincident with the consumption of a novel carbohydrate blocking supplement.

Conditions Studied

Interventions

  • DIETARY_SUPPLEMENT Placebo capsule
  • DIETARY_SUPPLEMENT Carbohydrate blocking supplement (CBS)

Study Locations (1)

Utah

  • doTERRA International - Pleasant Grove

Trial Details

FieldValue
Enrollment Target 43 participants
Start Date 2021-05-14
Est. Completion 2022-07-15
Phase NA

Sponsor

dōTERRA International

8 total trials

What the Registry Record Tells You About NCT05832463

The ClinicalTrials.gov registry entry for NCT05832463 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 43 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (93% lower). The listed sponsor is dōTERRA International, which has 8 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Healthy appearing as the primary indexed condition, and to 2 interventions - of which Placebo capsule is the first listed.

NCT05832463 reports 1 study location spanning 1 distinct geographic area - top geographies include Utah.

Frequently Asked Questions

What is clinical trial NCT05832463 about?

NCT05832463 is a clinical study titled "Effects of a Novel Supplement on Glycemic Variability Measured by Continuous Glucose Monitoring". This is a two-cohort, crossover pilot study to determine interstitial glucose levels coincident with the consumption of a novel carbohydrate blocking supplement.

What is the current status of trial NCT05832463?

This trial is currently completed. It is a NA study. The enrollment target is 43 participants. The study started on 2021-05-14. Estimated completion is 2022-07-15.

What conditions does trial NCT05832463 study?

This clinical trial studies the following conditions: Healthy.

What interventions are being tested in trial NCT05832463?

The interventions under investigation include: Placebo capsule (DIETARY_SUPPLEMENT), Carbohydrate blocking supplement (CBS) (DIETARY_SUPPLEMENT).

Who is sponsoring clinical trial NCT05832463?

This trial is sponsored by dōTERRA International, which has 8 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05832463 being conducted?

This trial has 1 study location across Utah. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Healthy

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.